Stella Metherell
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
Papers in
-
- COVID-19 Clinical Research Studies 16
- SARS-CoV-2 and COVID-19 Research 2
-
- Atrial Fibrillation Management and Outcomes 12
- Journals
- The Lancet (7 papers)JAMA (6 papers)Nature (4 papers)EP Europace (4 papers)BMC Medicine (2 papers)
- Partner nations
- United KingdomSerbiaDenmark
In The Last Decade
Stella Metherell
43 papers receiving 4.2k citations
Stella Metherell's Hit Papers
Peers
Comparison fields: 5 of 107
- Infectious Diseases 2.1k
- Cardiology and Cardiovascular Medicine 694
- Genetics 533
- Internal Medicine 46
- Applied Microbiology and Biotechnology 35
Countries citing papers authored by Stella Metherell
This map shows the geographic impact of Stella Metherell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Metherell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Metherell more than expected).
Fields of papers citing papers by Stella Metherell
This network shows the impact of papers produced by Stella Metherell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Metherell. The network helps show where Stella Metherell may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 269 |
| 6 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | 2021 | 213 | |
| 9 | 2021 | 166 | |
| 10 | 2016 | 145 | |
| 11 | 2017 | 137 | |
| 12 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 13 | 2022 | 120 | |
| 14 | 2022 | 105 | |
| 15 | 2022 | 100 | |
| 16 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 17 | 2021 | 72 | |
| 18 | 2019 | 68 | |
| 19 | 2022 | 61 | |
| 20 | 2023 | 60 |
About Stella Metherell
Stella Metherell is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Genetics, Surgery and Geriatrics and Gerontology, having authored 44 papers that have together received 4.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), Atrial Fibrillation Management and Outcomes (12 papers), Genetic Associations and Epidemiology (7 papers), Coronary Interventions and Diagnostics (4 papers), Respiratory Support and Mechanisms (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Cardiac Ischemia and Reperfusion (1 paper). The work is most often cited by research in Infectious Diseases (2.1k citations), Cardiology and Cardiovascular Medicine (694 citations), Genetics (533 citations), Internal Medicine (46 citations) and Applied Microbiology and Biotechnology (35 citations). Stella Metherell has collaborated with scholars based in United Kingdom, Serbia and Denmark. Their work appears in journals such as The Lancet, JAMA, Nature, EP Europace and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.